KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to 0.45.

  • Charles River Laboratories International's Equity Ratio fell 407.67% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year decrease of 407.67%. This contributed to the annual value of 0.46 for FY2024, which is 476.6% up from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Equity Ratio is 0.45, which was down 407.67% from 0.44 recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Equity Ratio ranged from a high of 0.47 in Q3 2024 and a low of 0.34 during Q3 2021
  • For the 5-year period, Charles River Laboratories International's Equity Ratio averaged around 0.41, with its median value being 0.42 (2023).
  • In the last 5 years, Charles River Laboratories International's Equity Ratio crashed by 630.11% in 2021 and then skyrocketed by 2204.66% in 2023.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Equity Ratio stood at 0.36 in 2021, then increased by 8.48% to 0.39 in 2022, then increased by 12.11% to 0.44 in 2023, then grew by 4.77% to 0.46 in 2024, then fell by 1.44% to 0.45 in 2025.
  • Its Equity Ratio stands at 0.45 for Q3 2025, versus 0.44 for Q2 2025 and 0.42 for Q1 2025.